Rhot1 Protein Miro1 Mitochondrial Rho Gtpase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Name | MIRO1 - Mitochondrial Rho GTPase 1 |
|---|
| Gene | RHOT1 |
|---|
| UniProt ID | Q8IXI1 |
|---|
| PDB Structures | 5ZAL, 5ZCM, 6G0W |
|---|
| Molecular Weight | 71.4 kDa (618 amino acids) |
|---|
| Subcellular Localization | Outer mitochondrial membrane (OMM) |
|---|
| Protein Family | Rho GTPase family, Miro family |
|---|
RHOT1 (Mitochondrial Rho GTPase 1), commonly known as MIRO1, is a 618-amino acid outer mitochondrial membrane protein that functions as a calcium-dependent GTPase and molecular adaptor controlling mitochondrial trafficking, dynamics, and quality control. MIRO1 serves as a critical interface between mitochondria and the cellular transport machinery, enabling neurons to dynamically redistribute energy-producing organelles to regions of high metabolic demand.
The MIRO1 protein possesses a unique architecture featuring an N-terminal GTPase domain followed by two EF-hand calcium-binding domains connected to a C-terminal transmembrane anchor. This structure allows MIRO1 to sense both the GTP/GDP state of the cell and calcium signals, integrating these inputs to regulate mitochondrial movement. When calcium levels rise at active synapses, MIRO1 binds calcium through its EF-hands, inducing a conformational change that arrests mitochondrial movement, allowing the organelle to supply ATP at the precise location where it is needed most.
Mutations in RHOT1 cause hereditary spastic paraplegia (HSP), and MIRO1 dysfunction has been strongly implicated in Parkinson's disease pathogenesis through its critical role in the PINK1/Parkin mitophagy pathway. The protein is therefore a key therapeutic target for neurodegenerative disorders characterized by mitochondrial dysfunction.
¶ Domain Architecture
MIRO1 contains several functionally distinct domains:
1. GTPase Domain (aa 1-300):
- N-terminal GTPase domain with Ras-like fold
- Binds GTP/GDP with high affinity
- Contains switch I and switch II regions typical of GTPases
- Catalytic activity modulated by calcium binding to EF-hands
- Interfaces with Milton adaptor proteins
2. EF-Hand Calcium-Binding Domains (aa 350-450):
- Two EF-hand motifs in tandem arrangement
- Bind calcium with micromolar affinity
- Conformational changes upon calcium binding halt mitochondrial movement
- Connect calcium signaling to transport machinery
3. Flexible Linker Region (aa 450-600):
- Intrinsically disordered region
- Provides flexibility for multiple protein interactions
- Contains serine/threonine phosphorylation sites
4. C-terminal Transmembrane Anchor (aa 600-618):
- Single transmembrane helix
- Anchors protein to outer mitochondrial membrane
- Preserves proper orientation of functional domains in cytosol
Crystal structures of MIRO1 GTPase domain (PDB: 5ZAL, 5ZCM) have revealed:
- GTPase fold similar to Ras family GTPases
- Conformational changes in switch regions during GTP hydrolysis
- Interface with Milton adaptor proteins
- How pathogenic mutations disrupt function
MIRO1 is the central regulator of mitochondrial trafficking in neurons:
Kinesin-Dependent Anterograde Transport:
- MIRO1 recruits Milton (TRAO1/TRAP1) adaptor proteins
- Milton links to kinesin-1 heavy chain
- Complex moves mitochondria from cell body to distal axons and synapses
- GTP-bound MIRO1 promotes active transport
Dynein-Dependent Retrograde Transport:
- Same MIRO1-Milton complex engages dynein
- Returns mitochondria from distal processes
- Required for quality control by delivering mitochondria to somata
Calcium-Dependent Stopping:
- Synaptic activity raises local calcium
- Calcium binding to EF-hands arrests mitochondrial movement
- Ensures mitochondria pause at energy-demanding synapses
- Prevents depletion of synaptic mitochondrial pools
MIRO1 coordinates mitophagy initiation:
- PINK1 phosphorylates MIRO1 upon mitochondrial damage
- Phosphorylated MIRO1 recruits Parkin E3 ubiquitin ligase
- Parkin ubiquitinates MIRO1 and other OMM proteins
- Ubiquitinated mitochondria are engulfed by autophagosomes
- MIRO1 itself is degraded during mitophagy
Proper mitochondrial distribution is essential for:
- Synaptic vesicle cycling
- Dendritic spine morphology
- Long-term potentiation
- Neuronal survival signaling
RHOT1 mutations cause autosomal recessive HSP:
- p.Arg272Cys: Most common, disrupts GTPase activity
- p.Arg372Trp: Impairs Milton interaction
- p.Lys369Glu: Reduces mitochondrial transport
Pathogenesis involves impaired axonal mitochondrial transport leading to degeneration of corticospinal tract neurons.
MIRO1 is a critical node in PD pathogenesis:
PINK1/Parkin Pathway:
- MIRO1 is a key PINK1 substrate
- Phosphorylation triggers mitophagy
- Mutations in this pathway cause early-onset PD
α-Synuclein Toxicity:
- α-Synuclein oligomers disrupt MIRO1 function
- Impaired mitochondrial transport precedes neuronal death
- MIRO1 restoration rescues some toxicity
LRRK2 Connection:
- LRRK2 mutations affect mitochondrial dynamics
- Interaction with MIRO1 pathway
- Dopaminergic neurons particularly vulnerable
Multiple mechanisms connect MIRO1 to AD:
- Synaptic Mitochondrial Depletion: Transport defects reduce synaptic mitochondria
- Amyloid-β Toxicity: Aβ directly impairs MIRO1 GTPase activity
- Tau Pathology: Pathological tau displaces MIRO1 from microtubules
- Calcium Dysregulation: AD disrupts calcium handling, affecting MIRO1 function
- ALS: Mitochondrial transport defects in motor neurons
- Huntington's Disease: Mutant huntingtin disrupts MIRO1-Milton interaction
- Charcot-Marie-Tooth Disease: Axonal degeneration from transport defects
- Diabetic Neuropathy: Mitochondrial dysfunction in peripheral neurons
MIRO1 is extensively modified:
- Phosphorylation: PINK1 phosphorylates Serine 242; other sites documented
- Ubiquitination: Parkin mediates K27-linked and K48-linked ubiquitination
- Proteolytic Cleavage: Caspase cleavage during apoptosis
- Sumoylation: Stress-responsive modification
Gene Therapy:
- AAV-mediated wild-type RHOT1 delivery for HSP
- CRISPR correction of pathogenic mutations
- Promoter optimization for neuron-specific expression
Small Molecules:
- MIRO1 GTPase activators/inhibitors
- Calcium channel modulators to reduce pathological calcium influx
- Mitochondrial transport enhancers
- Antioxidants: MitoQ, CoQ10 to reduce oxidative stress
- Autophagy Enhancers: Rapamycin, trehalose to promote mitophagy
- Metabolic Support: L-carnitine, alpha-lipoic acid for mitochondrial function
- Complex regulation by calcium and GTP/GDP state
- Must preserve both transport and quality control functions
- CNS delivery remains challenging
- Balancing motility (too much or too little can be harmful)
-
PMID:19053781 - MacAskill AF et al. MIRO1 is a calcium sensor for glutamate receptor trafficking. Neuron. 2009. (First description of MIRO1 calcium sensor function)
-
PMID:21423176 - Wang X et al. PINK1 and Parkin target MIRO1 for phosphorylation and degradation. Nature. 2011. (MIRO1 as key mitophagy substrate)
-
PMID:26344097 - Nguyen TT et al. RHOT1 mutations cause hereditary spastic paraplegia. Am J Hum Genet. 2015. (Genetic basis of RHOT1 HSP)
-
PMID:28178271 - Lopez-Domenech G et al. Miro1 regulates mitochondrial trafficking in neurons. J Cell Biol. 2018. (Comprehensive functional analysis)
-
PMID:31249466 - Mishra P et al. Miro1 deficiency causes axonal degeneration. Neuron. 2019. (Mechanistic insights)
-
PMID:35697654 - Schiavon CR et al. Miro1 deficiency recapitulates Parkinson's disease phenotypes. Nat Commun. 2022. (Miro1-PD connection)
The study of Rhot1 Protein Miro1 Mitochondrial Rho Gtpase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Fransson, S., et al. (2006). "Miro1 and mitochondrial trafficking in neurons." Journal of Cell Science. PMID:17099713.
- Nguyen, T.T., et al. (2014). "MIRO1 deficiency in Parkinson's disease." Movement Disorders. PMID:24664537.
- Wang, X., et al. (2011). "Mitochondrial dynamics in neurodegeneration." Trends in Cell Biology. PMID:21514164.
- MacAskill, A.F., et al. (2010). "Mitochondrial trafficking in neurons." Current Opinion in Neurobiology. PMID:20650536.